NCT00000392 arm group 6f8ce038bc50a5372fcaf86e4b300bb6 [clinicaltrials_resource:NCT00000392/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00000392 arm group 6f8ce038bc50a5372fcaf86e4b300bb6 [clinicaltrials_resource:NCT00000392/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6]
Bio2RDF identifier
NCT00000392/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 8ce038bc50a5372fcaf86e4b300bb6
description [clinicaltrials_vocabulary:description]
Placebo given intranasally at a dosage of 2mg 3 times a day for 6 months
identifier
clinicaltrials_resource:NCT00000392/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6
title
NCT00000392 arm group 6f8ce038bc50a5372fcaf86e4b300bb6
@en
type
label
NCT00000392 arm group 6f8ce038 ...... ce038bc50a5372fcaf86e4b300bb6]
@en